Schedule 13G ownership disclosure

Sunesis Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 867328700

Event date: 2019-01-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,935,481
Percent of class
8.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001687888-19-000001
Form type
SC 13G
Filer
JFL Capital Management, LLC
CIK
CIK 1687888
Filed
Jan 25, 2019
Reporting period
Jan 17, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub